86 related articles for article (PubMed ID: 2360622)
1. Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism.
Ramsammy L; Josepovitz C; Lane B; Kaloyanides GJ
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1141-9. PubMed ID: 2360622
[TBL] [Abstract][Full Text] [Related]
2. Effect of gentamicin on phospholipid metabolism in cultured rabbit proximal tubular cells.
Ramsammy LS; Josepovitz C; Lane B; Kaloyanides GJ
Am J Physiol; 1989 Jan; 256(1 Pt 1):C204-13. PubMed ID: 2492152
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
4. Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity.
Kaloyanides GJ
Ren Fail; 1992; 14(3):351-7. PubMed ID: 1509168
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin alters membrane structure as shown by freeze-fracture of liposomes.
Forge A; Zajic G; Davies S; Weiner N; Schacht J
Hear Res; 1989 Jan; 37(2):129-39. PubMed ID: 2536649
[TBL] [Abstract][Full Text] [Related]
6. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis.
Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM
Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282
[TBL] [Abstract][Full Text] [Related]
7. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
9. Gentamicin inhibits agonist stimulation of the phosphatidylinositol cascade in primary cultures of rabbit proximal tubular cells and in rat renal cortex.
Ramsammy LS; Josepovitz C; Kaloyanides GJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):989-96. PubMed ID: 2849680
[TBL] [Abstract][Full Text] [Related]
10. [Experimental observation of antagonism of polyaspartic acid against gentamicin-induced phospholipidosis in cochlea of guinea pig].
Guo Y; Jiang S; Yang W
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):931-3. PubMed ID: 11702670
[TBL] [Abstract][Full Text] [Related]
11. The effect of gentamicin on the biophysical properties of phosphatidic acid liposomes is influenced by the O-C = O group of the lipid.
Ramsammy LS; Kaloyanides GJ
Biochemistry; 1988 Oct; 27(21):8249-54. PubMed ID: 3233208
[TBL] [Abstract][Full Text] [Related]
12. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin-induced alterations in phospholipid metabolism in cultured human proximal tubular cells.
Chatterjee S
J Biochem Toxicol; 1987; 2():181-201. PubMed ID: 2854567
[TBL] [Abstract][Full Text] [Related]
14. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity.
Gilbert DN; Wood CA; Kohlhepp SJ; Kohnen PW; Houghton DC; Finkbeiner HC; Lindsley J; Bennett WM
J Infect Dis; 1989 May; 159(5):945-53. PubMed ID: 2651534
[TBL] [Abstract][Full Text] [Related]
15. Alterations in renal cortical phospholipid content induced by gentamicin: time course, specificity, and subcellular localization.
Knauss TC; Weinberg JM; Humes HD
Am J Physiol; 1983 May; 244(5):F535-46. PubMed ID: 6846542
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside antibiotics preferentially increase permeability in phosphoinositide-containing membranes: a study with carboxyfluorescein in liposomes.
Au S; Weiner ND; Schacht J
Biochim Biophys Acta; 1987 Aug; 902(1):80-6. PubMed ID: 3038190
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin-induced alterations in pig kidney epithelial (LLC-PK1) cells in culture.
Schwertz DW; Kreisberg JI; Venkatachalam MA
J Pharmacol Exp Ther; 1986 Jan; 236(1):254-62. PubMed ID: 3941396
[TBL] [Abstract][Full Text] [Related]
18. Pig kidney (LLC-PK1) cell membrane fluidity during exposure to gentamicin or tobramycin.
Kohlhepp SJ; Hou L; Gilbert DN
Antimicrob Agents Chemother; 1994 Sep; 38(9):2169-71. PubMed ID: 7811038
[TBL] [Abstract][Full Text] [Related]
19. Molecular parameters involved in aminoglycoside nephrotoxicity.
Mingeot-Leclercq MP; Brasseur R; Schanck A
J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
